R
Ralph B. D'Agostino
Researcher at Wake Forest University
Publications - 1336
Citations - 250792
Ralph B. D'Agostino is an academic researcher from Wake Forest University. The author has contributed to research in topics: Framingham Heart Study & Framingham Risk Score. The author has an hindex of 226, co-authored 1287 publications receiving 229636 citations. Previous affiliations of Ralph B. D'Agostino include VA Boston Healthcare System & University of Illinois at Urbana–Champaign.
Papers
More filters
Journal ArticleDOI
Identification of Subjects with Insulin Resistance and β-Cell Dysfunction Using Alternative Definitions of the Metabolic Syndrome
Anthony J.G. Hanley,Lynne E. Wagenknecht,Ralph B. D'Agostino,Bernard Zinman,Steven M. Haffner +4 more
TL;DR: Although both the WHO and NCEP MetS criteria identify nondiabetic individuals with low insulin sensitivity, the associations were notably stronger using the WHO definition, although the definitions are generally less useful for identifying those with low AIR or DI.
Journal ArticleDOI
Associations of Carotid Artery Intima-Media Thickness (IMT) With Risk Factors and Prevalent Cardiovascular Disease: Comparison of Mean Common Carotid Artery IMT With Maximum Internal Carotid Artery IMT
Joseph F. Polak,Michael J. Pencina,Allison Meisner,Karol M. Pencina,Lisa S. Brown,Philip A. Wolf,Ralph B. D'Agostino +6 more
TL;DR: ociation of risk factors with CCA and ICA IMT are slightly different, and both are independently associated with prevalent CVD, and their value for predicting incident cardiovascular events needs to be compared in outcome studies.
Journal ArticleDOI
Association of Circulating Cholesteryl Ester Transfer Protein Activity With Incidence of Cardiovascular Disease in the Community
Ramachandran S. Vasan,Michael J. Pencina,Sander J. Robins,Justin P. Zachariah,Guneet Kaur,Ralph B. D'Agostino,Jose M. Ordovas +6 more
TL;DR: In a prospective investigation of a community-based sample, lower plasma CETP activity was associated with greater CVD risk, challenging the concept that CETP inhibition may lower CVDrisk.
Journal ArticleDOI
Testing the Accelerator Hypothesis: Body size, β-cell function, and age at onset of type 1 (autoimmune) diabetes
Dana Dabelea,Ralph B. D'Agostino,Elizabeth J. Mayer-Davis,David J. Pettitt,Giuseppina Imperatore,L. M. Dolan,Catherine Pihoker,Teresa A. Hillier,Santica M. Marcovina,Barbara Linder,Andrea Ruggiero,Richard F. Hamman +11 more
TL;DR: Increasing BMI is associated with younger age at diagnosis of type 1 diabetes only among those U.S. youth with reduced beta-cell function and the intrauterine environment may also be an important determinant of age at onset oftype 1 diabetes.
Journal ArticleDOI
Prevention Conference V Beyond Secondary Prevention : Identifying the High-Risk Patient for Primary Prevention : Medical Office Assessment : Writing Group I
Scott M. Grundy,Terry L. Bazzarre,James I. Cleeman,Ralph B. D'Agostino,Martha N. Hill,Nancy Houston-Miller,William B. Kannel,Ronald M. Krauss,Harlan M. Krumholz,Ronald M. Lauer,Ira S. Ockene,Richard C. Pasternak,Thomas A. Pearson,Paul M. Ridker,Darien Wood +14 more
TL;DR: The role of medical office assessment in the detection of risk factors and estimation of total cardiovascular risk was reviewed, with a primary focus on identification of known risk factors for coronary heart disease (CHD).